166 related articles for article (PubMed ID: 16790554)
1. Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.
Bernard O; Tojcic J; Journault K; Perusse L; Guillemette C
Drug Metab Dispos; 2006 Sep; 34(9):1539-45. PubMed ID: 16790554
[TBL] [Abstract][Full Text] [Related]
2. The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.
Lévesque E; Delage R; Benoit-Biancamano MO; Caron P; Bernard O; Couture F; Guillemette C
Clin Pharmacol Ther; 2007 Mar; 81(3):392-400. PubMed ID: 17339869
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acyl-glucuronide metabolite.
Dostalek M; Court MH; Hazarika S; Akhlaghi F
Drug Metab Dispos; 2011 Mar; 39(3):448-55. PubMed ID: 21123165
[TBL] [Abstract][Full Text] [Related]
4. Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.
Djebli N; Picard N; Rérolle JP; Le Meur Y; Marquet P
Pharmacogenet Genomics; 2007 May; 17(5):321-30. PubMed ID: 17429314
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Study on Influences of UGT1A8 Gene Polymorphisms on Mycophenolate Mofetil Metabolism.
Zhou Z; Lu Y; Song G; Wang Y; Chen J; Xiao C; Zhong L; Sun X; Peng Z; Wang X
Exp Clin Transplant; 2018 Aug; 16(4):466-472. PubMed ID: 29025387
[TBL] [Abstract][Full Text] [Related]
6. Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients.
Xie XC; Li J; Wang HY; Li HL; Liu J; Fu Q; Huang JW; Zhu C; Zhong GP; Wang XD; Sun PP; Huang M; Wang CX; Li JL
Acta Pharmacol Sin; 2015 May; 36(5):644-50. PubMed ID: 25864649
[TBL] [Abstract][Full Text] [Related]
7. Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.
Zhang WX; Chen B; Jin Z; Yu Z; Wang X; Chen H; Mao A; Cai W
Xenobiotica; 2008 Nov; 38(11):1422-36. PubMed ID: 18946804
[TBL] [Abstract][Full Text] [Related]
8. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
van Agteren M; Armstrong VW; van Schaik RH; de Fijter H; Hartmann A; Zeier M; Budde K; Kuypers D; Pisarski P; Le Meur Y; van der Werf M; Mamelok RD; Oellerich M; van Gelder T
Ther Drug Monit; 2008 Aug; 30(4):439-44. PubMed ID: 18641546
[TBL] [Abstract][Full Text] [Related]
9. C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.
Baldelli S; Merlini S; Perico N; Nicastri A; Cortinovis M; Gotti E; Remuzzi G; Cattaneo D
Pharmacogenomics; 2007 Sep; 8(9):1127-41. PubMed ID: 17924828
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study.
Ting LS; Benoit-Biancamano MO; Bernard O; Riggs KW; Guillemette C; Ensom MH
Pharmacotherapy; 2010 Nov; 30(11):1097-108. PubMed ID: 20973683
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid.
Miles KK; Kessler FK; Smith PC; Ritter JK
Drug Metab Dispos; 2006 Sep; 34(9):1632-9. PubMed ID: 16790558
[TBL] [Abstract][Full Text] [Related]
12. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
[TBL] [Abstract][Full Text] [Related]
13. Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.
Shipkova M; Strassburg CP; Braun F; Streit F; Gröne HJ; Armstrong VW; Tukey RH; Oellerich M; Wieland E
Br J Pharmacol; 2001 Mar; 132(5):1027-34. PubMed ID: 11226133
[TBL] [Abstract][Full Text] [Related]
14. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.
Miura M; Kagaya H; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
Ther Drug Monit; 2008 Oct; 30(5):559-64. PubMed ID: 18695635
[TBL] [Abstract][Full Text] [Related]
15. Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
Kagaya H; Inoue K; Miura M; Satoh S; Saito M; Tada H; Habuchi T; Suzuki T
Eur J Clin Pharmacol; 2007 Mar; 63(3):279-88. PubMed ID: 17211619
[TBL] [Abstract][Full Text] [Related]
16. Effect of UDP-glucuronosyltransferase 1A8 polymorphism on raloxifene glucuronidation.
Kokawa Y; Kishi N; Jinno H; Tanaka-Kagawa T; Narimatsu S; Hanioka N
Eur J Pharm Sci; 2013 May; 49(2):199-205. PubMed ID: 23499758
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
[TBL] [Abstract][Full Text] [Related]
18. Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid.
Mackenzie PI
Ther Drug Monit; 2000 Feb; 22(1):10-3. PubMed ID: 10688250
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers.
Lévesque E; Benoit-Biancamano MO; Delage R; Couture F; Guillemette C
Pharmacogenomics; 2008 Jul; 9(7):869-79. PubMed ID: 18597651
[TBL] [Abstract][Full Text] [Related]
20. Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver.
Iwamura A; Fukami T; Higuchi R; Nakajima M; Yokoi T
J Biol Chem; 2012 Mar; 287(12):9240-9. PubMed ID: 22294686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
